Identification of risk factors and metabolic monitoring practices in patients on antipsychotic drugs in South India

Poojari, Pooja Gopal and Acharya, Leelavathi D and Kunhikatta, Vijayanarayana and Thunga, Girish and Shenoy, Sonia and Shetty, Sahana and Bose, Swarnali (2020) Identification of risk factors and metabolic monitoring practices in patients on antipsychotic drugs in South India. Asian Journal of Psychiatry, 53. ISSN 18762018

[img] PDF
VANI 10347 DisplayPdf.pdf - Published Version
Restricted to Registered users only

Download (3MB) | Request a copy

Abstract

The objectives of this study were to identify the risk factors for metabolic syndrome in patients on antipsychotics and to compare the frequency of metabolic monitoring with evidence-based guidelines. We conducted a retrospective cohort study in a tertiary care health institution of South India. The study included patients with schizophrenia, bipolar disorder, and schizoaffective disorders prescribed with antipsychotic drugs. Data was collected from the medical records department. American Diabetic Association/American Psychiatric Association (ADA/APA) guidelines were used as a reference standard to assess the monitoring for metabolic parameters. Diagnosis of metabolic syndrome was done according to the National Cholesterol Education Program-Adult Treatment Panel III (NCEP-ATP III) guidelines. Risk factors for metabolic syndrome and frequency of metabolic monitoring were analyzed. A total of 668 patients were included for clinical audit. About 16.5 % of the patients were diagnosed with metabolic syndrome. Age >50 years (Odds Ratio (OR) 2.00; p value <0.001) and duration of antipsychotic treatment>5 years (OR 1.55; p value< 0.05) were recognized as the independent risk factors for metabolic syndrome using multiple logistic regression. Blood pressure (BP) and fasting blood sugar (FBS) levels were documented in 99.7 % and 47 % of cases at baseline respectively, however, subsequent annual data on BP and FBS monitoring was reduced to 72.7 % and 46 % respectively. Weight was documented in 60 % of the cases at baseline, whereas the subsequent data on four times the annual assessment of weight was reduced to 9.8 %. The extent of documentation of metabolic monitoring parameters was inadequate.

Item Type: Article
Uncontrolled Keywords: Adverse drug reactions; Antipsychotics; Metabolic monitoring; Metabolic syndrome; Risk
Subjects: Allied Health > MCOAHS Manipal > Clinical Psychology
Medicine > KMC Manipal > Medicine
Pharmacy > MCOPS Manipal > Pharmacy Practice
Medicine > KMC Manipal > Psychiatry
Depositing User: KMC Library
Date Deposited: 27 Jan 2021 12:02
Last Modified: 27 Jan 2021 12:02
URI: http://eprints.manipal.edu/id/eprint/156257

Actions (login required)

View Item View Item